These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 20981502)

  • 21. Diagnostic performance of ultrasonic tissue characterization for subendocardial ischaemia in patients with hypertrophic cardiomyopathy.
    Kawasaki T; Yamano M; Sakai C; Harimoto K; Miki S; Kamitani T; Sugihara H
    Eur Heart J Cardiovasc Imaging; 2013 Aug; 14(8):790-6. PubMed ID: 23221313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of Hypertrophic Cardiomyopathy: Newer Echo and MRI Approaches.
    Habib M; Hoss S; Rakowski H
    Curr Cardiol Rep; 2019 Jun; 21(8):75. PubMed ID: 31243594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comprehensive evaluation of myocardial fibrosis in hypertrophic cardiomyopathy with cardiac magnetic resonance imaging: linking genotype with fibrotic phenotype.
    Ellims AH; Iles LM; Ling LH; Chong B; Macciocca I; Slavin GS; Hare JL; Kaye DM; Marasco SF; McLean CA; James PA; du Sart D; Taylor AJ
    Eur Heart J Cardiovasc Imaging; 2014 Oct; 15(10):1108-16. PubMed ID: 24819852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Left atrial fibrosis correlates with extent of left ventricular myocardial delayed enhancement and left ventricular strain in hypertrophic cardiomyopathy.
    Latif SR; Nguyen VQ; Peters DC; Soufer A; Henry ML; Grunseich K; Testani J; Hur DJ; Huber S; Mojibian H; Dicks D; Sinusas AJ; Meadows JL; Papoutsidakis N; Jacoby D; Baldassarre LA
    Int J Cardiovasc Imaging; 2019 Jul; 35(7):1309-1318. PubMed ID: 30790116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extent of late gadolinium enhancement at right ventricular insertion points in patients with hypertrophic cardiomyopathy: relation with diastolic dysfunction.
    Zhu Y; Park EA; Lee W; Kim HK; Chu A; Chung JW; Park JH
    Eur Radiol; 2015 Apr; 25(4):1190-200. PubMed ID: 25597022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenotypic expression in hypertrophic cardiomyopathy and late gadolinium enhancement on cardiac magnetic resonance.
    Caetano F; Botelho A; Trigo J; Silva J; Almeida I; Venâncio M; Pais J; Sanches C; Leitão Marques A
    Rev Port Cardiol; 2014 May; 33(5):261-7. PubMed ID: 24909443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical significance of global two-dimensional strain as a surrogate parameter of myocardial fibrosis and cardiac events in patients with hypertrophic cardiomyopathy.
    Saito M; Okayama H; Yoshii T; Higashi H; Morioka H; Hiasa G; Sumimoto T; Inaba S; Nishimura K; Inoue K; Ogimoto A; Shigematsu Y; Hamada M; Higaki J
    Eur Heart J Cardiovasc Imaging; 2012 Jul; 13(7):617-23. PubMed ID: 22271116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systolic function reserve using two-dimensional strain imaging in hypertrophic cardiomyopathy: comparison with essential hypertension.
    Badran HM; Faheem N; Ibrahim WA; Elnoamany MF; Elsedi M; Yacoub M
    J Am Soc Echocardiogr; 2013 Dec; 26(12):1397-406. PubMed ID: 24094559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitral annular plane systolic excursion is an easy tool for fibrosis detection by late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
    Doesch C; Sperb A; Sudarski S; Lossnitzer D; Rudic B; Tülümen E; Heggemann F; Schimpf R; Schoenberg SO; Borggrefe M; Papavassiliu T
    Arch Cardiovasc Dis; 2015; 108(6-7):356-66. PubMed ID: 25863428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myocardial perfusion reserve quantified by cardiac magnetic resonance imaging is associated with late gadolinium enhancement in hypertrophic cardiomyopathy.
    Tezuka D; Kosuge H; Terashima M; Koyama N; Kishida T; Tada Y; Suzuki JI; Sasano T; Ashikaga T; Hirao K; Isobe M
    Heart Vessels; 2018 May; 33(5):513-520. PubMed ID: 29168014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Usefulness of delayed enhancement magnetic resonance imaging to differentiate dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy.
    Matoh F; Satoh H; Shiraki K; Saitoh T; Urushida T; Katoh H; Takehara Y; Sakahara H; Hayashi H
    J Card Fail; 2007 Jun; 13(5):372-9. PubMed ID: 17602984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accuracy of Jet Direction on Doppler Echocardiography in Identifying the Etiology of Mitral Regurgitation in Obstructive Hypertrophic Cardiomyopathy.
    Hang D; Schaff HV; Nishimura RA; Lahr BD; Abel MD; Dearani JA; Ommen SR
    J Am Soc Echocardiogr; 2019 Mar; 32(3):333-340. PubMed ID: 30598365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myocardial fibrosis in patients with symptomatic obstructive hypertrophic cardiomyopathy: correlation with echocardiographic measurements, sarcomeric genotypes, and pro-left ventricular hypertrophy polymorphisms involving the renin-angiotensin-aldosterone system.
    Blauwet LA; Ackerman MJ; Edwards WD; Riehle DL; Ommen SR
    Cardiovasc Pathol; 2009; 18(5):262-8. PubMed ID: 18835191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Characterization of hypertrophic cardiomyopathy with magnetic resonance].
    Di Cesare E; Marsili L; Chichiarelli A; Di Renzi P; Costanzi A; Lupattelli L
    Radiol Med; 1994 May; 87(5):614-9. PubMed ID: 8008891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Late gadolinium enhancement is common in patients with hypertrophic cardiomyopathy and no clinical risk factors for sudden cardiac death: A single center experience.
    Lyons KS; Dixon LJ; Johnston N; Noad R; Hamilton A; McKeag N; Horan P
    Cardiol J; 2014; 21(1):29-32. PubMed ID: 23990187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantification and significance of diffuse myocardial fibrosis and diastolic dysfunction in childhood hypertrophic cardiomyopathy.
    Hussain T; Dragulescu A; Benson L; Yoo SJ; Meng H; Windram J; Wong D; Greiser A; Friedberg M; Mertens L; Seed M; Redington A; Grosse-Wortmann L
    Pediatr Cardiol; 2015 Jun; 36(5):970-8. PubMed ID: 25605038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myocardial constructive work is impaired in hypertrophic cardiomyopathy and predicts left ventricular fibrosis.
    Galli E; Vitel E; Schnell F; Le Rolle V; Hubert A; Lederlin M; Donal E
    Echocardiography; 2019 Jan; 36(1):74-82. PubMed ID: 30488501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regional left ventricular myocardial contraction abnormalities and asynchrony in patients with hypertrophic cardiomyopathy evaluated by magnetic resonance spatial modulation of magnetization myocardial tagging.
    Mishiro Y; Oki T; Iuchi A; Tabata T; Yamada H; Abe M; Onose Y; Ito S; Nishitani H; Harada M; Taoka Y
    Jpn Circ J; 1999 Jun; 63(6):442-6. PubMed ID: 10406583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristic myocardial strain identified in hypertrophic cardiomyopathy subjects with preserved left ventricular ejection fraction using a novel multi-layer transthoracic echocardiography technique.
    Ozawa K; Funabashi N; Takaoka H; Kamata T; Kanaeda A; Saito M; Nomura F; Kobayashi Y
    Int J Cardiol; 2015 Apr; 184():237-243. PubMed ID: 25723651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of future onset of atrial fibrillation in hypertrophic cardiomyopathy.
    Cochet H; Morlon L; Vergé MP; Salel M; Camaioni C; Reynaud A; Peyrou J; Ritter P; Jais P; Laurent F; Lafitte S; Montaudon M; Réant P
    Arch Cardiovasc Dis; 2018 Oct; 111(10):591-600. PubMed ID: 29884599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.